Ozone protects cardiomyocytes from myocardial ischemia–reperfusion injury through miR-200c/FOXO3 axis

References

• Kasargod Prabhakar CR, Stewart R. Physical activity and mortality in patients with stable coronary heart disease. Curr Opin Cardiol. 2018;33(6):653–659.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92–100.
   PubMed Web of Science ®Google Scholar
• Binder A, Ali A, Chawla R, et al. Myocardial protection from ischemia-reperfusion injury post coronary revascularization. Expert Rev Cardiovasc Ther. 2015;13(9):1045–1057.
   PubMed Web of Science ®Google Scholar
• Wang J, Toan S, Zhou H. New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis. 2020;23(3):299–314.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou H. Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury. Acta Pharm Sin B. 2020;10(10):1866–1879.
   PubMed Web of Science ®Google Scholar
• Ong SB, Hernández-Reséndiz S, Crespo-Avilan GE, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:73–87.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang A, Meng W, et al. Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis. Eur J Pharmacol. 2018;835:82–93.
   PubMed Web of Science ®Google Scholar
• Guo X, Hu S, Liu JJ, et al. Piperine protects against pyroptosis in myocardial ischaemia/reperfusion injury by regulating the miR-383/RP105/AKT signalling pathway. J Cell Mol Med. 2021;25(1):244–258.
   PubMed Web of Science ®Google Scholar
• Romaine SP, Tomaszewski M, Condorelli G, et al. MicroRNAs in cardiovascular disease: an introduction for clinicians. Heart. 2015;101(12):921–928.
   PubMed Web of Science ®Google Scholar
• Han X, Chen X, Han J, et al. MiR-324/SOCS3 axis protects against hypoxia/reoxygenation-induced cardiomyocyte injury and regulates myocardial ischemia via TNF/NF-κB signaling pathway. Int Heart J. 2020;61(6):1258–1269.
   PubMed Web of Science ®Google Scholar
• Magenta A, Cencioni C, Fasanaro P, et al. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ. 2011;18(10):1628–1639.
   PubMed Web of Science ®Google Scholar
• Magenta A, D’Agostino M, Sileno S, et al. The oxidative stress-induced miR-200c is upregulated in psoriasis and correlates with disease severity and determinants of cardiovascular risk. Oxid Med Cell Longev. 2019;2019:1–12.
   Web of Science ®Google Scholar
• Magenta A, Ciarapica R, Capogrossi MC. The emerging role of miR-200 family in cardiovascular diseases. Circ Res. 2017;120(9):1399–1402.
   PubMed Web of Science ®Google Scholar
• Liu F, Li Y, Liu G. MicroRNA-200c exacerbates the ischemia/reperfusion injury of heart through targeting the glutaminase (GLS)-mediated glutamine metabolism. Eur Rev Med Pharmacol Sci. 2017;21(14):3282–3289.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang S, Guo C, et al. Downregulation of miR-200c protects cardiomyocytes from hypoxia-induced apoptosis by targeting GATA-4. Int J Mol Med. 2017;39(6):1589–1596.
   PubMed Web of Science ®Google Scholar
• Obsil T, Obsilova V. Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene. 2008;27(16):2263–2275.
   PubMed Web of Science ®Google Scholar
• Chapuis N, Park S, Leotoing L, et al. IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia. Blood. 2010;116(20):4240–4250.
   PubMed Web of Science ®Google Scholar
• Xin Z, Ma Z, Jiang S, et al. FOXOs in the impaired heart: new therapeutic targets for cardiac diseases. Biochim Biophys Acta Mol Basis Dis. 2017;1863(2):486–498.
   PubMed Web of Science ®Google Scholar
• Lv W, Jiang J, Li Y, et al. MiR-302a-3p aggravates myocardial ischemia-reperfusion injury by suppressing mitophagy via targeting FOXO3. Exp Mol Pathol. 2020;117:104522.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Garcia-Dorado D, Botker HE, et al. Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology Working Group on cellular biology of the heart. Cardiovasc Res. 2017;113(6):564–585.
   PubMed Web of Science ®Google Scholar
• Heusch G, Rassaf T. Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning. Circ Res. 2016;119(5):676–695.
   PubMed Web of Science ®Google Scholar
• Arvola O, Griffiths B, Rao A, et al. Expression of miR-200c corresponds with increased reactive oxygen species and hypoxia markers after transient focal ischemia in mice. Neurochem Int. 2021;149:105146.
   PubMed Web of Science ®Google Scholar
• Xue B, Chuang CH, Prosser HM, et al. miR-200 deficiency promotes lung cancer metastasis by activating notch signaling in cancer-associated fibroblasts. Genes Dev. 2021;35(15–16):1109–1122.
   PubMed Web of Science ®Google Scholar
• Anastasiadou E, Messina E, Sanavia T, et al. MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of beta-catenin and c-Myc. Cells. 2021;10(3):519.
   PubMed Web of Science ®Google Scholar
• Williams MM, Christenson JL, O'Neill KI, et al. MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer. NPJ Breast Cancer. 2021;7(1):64.
   PubMed Web of Science ®Google Scholar
• Poon EN, Hao B, Guan D, et al. Integrated transcriptomic and regulatory network analyses identify microRNA-200c as a novel repressor of human pluripotent stem cell-derived cardiomyocyte differentiation and maturation. Cardiovasc Res. 2018;114(6):894–906.
   PubMed Web of Science ®Google Scholar
• Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci. 2007;120*(Pt 15):2479–2487.
   PubMed Web of Science ®Google Scholar
• Tremblay ML, Giguere V. Phosphatases at the heart of FoxO metabolic control. Cell Metab. 2008;7(2):101–103.
   PubMed Web of Science ®Google Scholar